Articles published by Cyclacel
![](https://ml.globenewswire.com/media/6b33b8cc-7364-4fd6-9ed3-0c65a1516e50/small/cyclacel-pharmaceuticals-logo.jpg)
![](https://ml.globenewswire.com/media/6b33b8cc-7364-4fd6-9ed3-0c65a1516e50/small/cyclacel-pharmaceuticals-logo.jpg)
![](https://ml.globenewswire.com/media/6b33b8cc-7364-4fd6-9ed3-0c65a1516e50/small/cyclacel-pharmaceuticals-logo.jpg)
![](https://ml.globenewswire.com/media/6b33b8cc-7364-4fd6-9ed3-0c65a1516e50/small/cyclacel-pharmaceuticals-logo.jpg)
From Cyclacel
Via GlobeNewswire
![](https://ml.globenewswire.com/media/6b33b8cc-7364-4fd6-9ed3-0c65a1516e50/small/cyclacel-pharmaceuticals-logo.jpg)
![](https://ml.globenewswire.com/media/6b33b8cc-7364-4fd6-9ed3-0c65a1516e50/small/cyclacel-pharmaceuticals-logo.jpg)
![](https://ml.globenewswire.com/media/6b33b8cc-7364-4fd6-9ed3-0c65a1516e50/small/cyclacel-pharmaceuticals-logo.jpg)
![](https://ml.globenewswire.com/media/6b33b8cc-7364-4fd6-9ed3-0c65a1516e50/small/cyclacel-pharmaceuticals-logo.jpg)
![](https://ml.globenewswire.com/media/6b33b8cc-7364-4fd6-9ed3-0c65a1516e50/small/cyclacel-pharmaceuticals-logo.jpg)
![](https://ml.globenewswire.com/media/6b33b8cc-7364-4fd6-9ed3-0c65a1516e50/small/cyclacel-pharmaceuticals-logo.jpg)
![](https://ml.globenewswire.com/media/6b33b8cc-7364-4fd6-9ed3-0c65a1516e50/small/cyclacel-pharmaceuticals-logo.jpg)
From Cyclacel
Via GlobeNewswire
![](https://ml.globenewswire.com/media/6b33b8cc-7364-4fd6-9ed3-0c65a1516e50/small/cyclacel-pharmaceuticals-logo.jpg)
From Cyclacel
Via GlobeNewswire
![](https://ml.globenewswire.com/media/6b33b8cc-7364-4fd6-9ed3-0c65a1516e50/small/cyclacel-pharmaceuticals-logo.jpg)
![](https://ml.globenewswire.com/media/6b33b8cc-7364-4fd6-9ed3-0c65a1516e50/small/cyclacel-pharmaceuticals-logo.jpg)
Cyclacel Pharmaceuticals Regains Compliance With Nasdaq Minimum Bid Price Requirement
January 08, 2024
From Cyclacel
Via GlobeNewswire
![](https://ml.globenewswire.com/media/6b33b8cc-7364-4fd6-9ed3-0c65a1516e50/small/cyclacel-pharmaceuticals-logo.jpg)
Cyclacel Pharmaceuticals to Present at Biotech Showcase 2024
January 02, 2024
From Cyclacel
Via GlobeNewswire
![](https://ml.globenewswire.com/media/6b33b8cc-7364-4fd6-9ed3-0c65a1516e50/small/cyclacel-pharmaceuticals-logo.jpg)
![](https://ml.globenewswire.com/media/6b33b8cc-7364-4fd6-9ed3-0c65a1516e50/small/cyclacel-pharmaceuticals-logo.jpg)
![](https://ml.globenewswire.com/media/6b33b8cc-7364-4fd6-9ed3-0c65a1516e50/small/cyclacel-pharmaceuticals-logo.jpg)
Cyclacel Pharmaceuticals Announces Reverse Stock Split
December 12, 2023
From Cyclacel
Via GlobeNewswire
![](https://ml.globenewswire.com/media/6b33b8cc-7364-4fd6-9ed3-0c65a1516e50/small/cyclacel-pharmaceuticals-logo.jpg)
![](https://ml.globenewswire.com/media/6b33b8cc-7364-4fd6-9ed3-0c65a1516e50/small/cyclacel-pharmaceuticals-logo.jpg)
![](https://ml.globenewswire.com/media/6b33b8cc-7364-4fd6-9ed3-0c65a1516e50/small/cyclacel-pharmaceuticals-logo.jpg)
Cyclacel Pharmaceuticals Reports Third Quarter Financial Results and Provides Business Update
November 13, 2023
From Cyclacel
Via GlobeNewswire
![](https://ml.globenewswire.com/media/6b33b8cc-7364-4fd6-9ed3-0c65a1516e50/small/cyclacel-pharmaceuticals-logo.jpg)
Cyclacel Pharmaceuticals to Release Third Quarter 2023 Financial Results
November 07, 2023
From Cyclacel
Via GlobeNewswire
![](https://ml.globenewswire.com/media/6b33b8cc-7364-4fd6-9ed3-0c65a1516e50/small/cyclacel-pharmaceuticals-logo.jpg)
![](https://ml.globenewswire.com/media/6b33b8cc-7364-4fd6-9ed3-0c65a1516e50/small/cyclacel-pharmaceuticals-logo.jpg)
From Cyclacel
Via GlobeNewswire
![](https://ml.globenewswire.com/media/6b33b8cc-7364-4fd6-9ed3-0c65a1516e50/small/cyclacel-pharmaceuticals-logo.jpg)
![](https://ml.globenewswire.com/media/6b33b8cc-7364-4fd6-9ed3-0c65a1516e50/small/cyclacel-pharmaceuticals-logo.jpg)
From Cyclacel
Via GlobeNewswire
![](https://ml.globenewswire.com/media/6b33b8cc-7364-4fd6-9ed3-0c65a1516e50/small/cyclacel-pharmaceuticals-logo.jpg)
From Cyclacel
Via GlobeNewswire
![](https://ml.globenewswire.com/media/6b33b8cc-7364-4fd6-9ed3-0c65a1516e50/small/cyclacel-pharmaceuticals-logo.jpg)
From Cyclacel
Via GlobeNewswire
![](https://ml.globenewswire.com/media/6b33b8cc-7364-4fd6-9ed3-0c65a1516e50/small/cyclacel-pharmaceuticals-logo.jpg)
![](https://ml.globenewswire.com/media/6b33b8cc-7364-4fd6-9ed3-0c65a1516e50/small/cyclacel-pharmaceuticals-logo.jpg)
Cyclacel Pharmaceuticals to Release Fourth Quarter and Full Year 2022 Financial Results
February 27, 2023
From Cyclacel
Via GlobeNewswire
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.